Department of Oral Medicine and Periodontology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1257-1264. doi: 10.31557/APJCP.2024.25.4.1257.
Previous study showed aberrant CLLD7 and CHC1L protein expression in oral squamous cell carcinoma (OSCC) compared to normal oral mucosa (NOM). This study aimed to evaluate the expression of these proteins in oral epithelial dysplasia (OED).
Forty specimens of OED and 11 NOM were used. The expression of CLLD7 and CHC1L was determined by immunohistochemistry. In each case, at least 1000 cells were counted. Presence of nuclear, cytoplasmic, and/or membrane staining of CLLD7 and CHC1L were considered positive. Percentages of total positive cells and positive cells at different locations were recorded. SPSS version 18 was used to compare variation between groups with statistical significance at p<0.05.
No significant differences in the percentages of total positive cells of CLLD7 and CHC1L were found between NOM and all grades of OED. Nevertheless, there were significant differences in subcellular staining of these two proteins. In CLLD7, the nuclear staining of the moderate and the severe OED groups was significantly lower than that of the NOM group (p<0.05). The percentages of membrane staining of CHC1L in moderate and severe OED were significantly higher than that of NOM (p<0.001). In addition, the nuclear staining of CHC1L in each grade of OED was significantly lower than that of NOM (p<0.05).
The subcellular mislocalization of CLLD7 and CHC1L in OED suggests that the expression of these potential tumor suppressor proteins might be dysregulated during the dysplastic process. The distinct membrane staining of CHC1L observed in OED but not in NOM is a useful characteristic that can be used to separate OED from NOM. Thus, CHC1L may be a good marker to assist in the diagnosis of OED.
先前的研究表明,与正常口腔黏膜(NOM)相比,口腔鳞状细胞癌(OSCC)中存在 CLLD7 和 CHC1L 蛋白的异常表达。本研究旨在评估这些蛋白在口腔上皮异型增生(OED)中的表达情况。
本研究使用了 40 份 OED 标本和 11 份 NOM。通过免疫组织化学检测 CLLD7 和 CHC1L 的表达。在每种情况下,至少计数 1000 个细胞。将 CLLD7 和 CHC1L 的核、细胞质和/或膜染色视为阳性。记录总阳性细胞百分比和不同部位的阳性细胞百分比。使用 SPSS 版本 18 比较组间差异,p<0.05 为具有统计学意义。
NOM 和所有 OED 分级之间 CLLD7 和 CHC1L 的总阳性细胞百分比无显著差异。然而,这两种蛋白的亚细胞染色存在显著差异。在 CLLD7 中,中重度 OED 组的核染色明显低于 NOM 组(p<0.05)。中重度 OED 中 CHC1L 的膜染色百分比明显高于 NOM(p<0.001)。此外,各 OED 分级中 CHC1L 的核染色均明显低于 NOM(p<0.05)。
OED 中 CLLD7 和 CHC1L 的亚细胞定位异常提示这些潜在肿瘤抑制蛋白的表达可能在异型增生过程中失调。在 OED 中观察到但在 NOM 中未观察到的 CHC1L 独特的膜染色是一个有用的特征,可用于将 OED 与 NOM 区分开来。因此,CHC1L 可能是辅助诊断 OED 的良好标志物。